Renal Cancer - Results from #8380

Duration of targeted therapy for metastatic renal cell carcinoma: A review of current practices - Abstract July 12, 2012

Patterns of interstitial lung disease during everolimus treatment in patients with metastatic renal cell carcinoma - Abstract July 11, 2012

Progression free survival of first line vascular endothelial growth factor-targeted therapy is an important prognostic parameter in patients with metastatic renal cell carcinoma - Abstract July 11, 2012

Severe paraneoplastic hypereosinophilia in metastatic renal cell carcinoma - Abstract July 10, 2012

Circulating biomarkers in advanced renal cell carcinoma: Clinical applications - Abstract July 10, 2012

Impact of comorbidity on complications after nephrectomy: Use of the Clavien Classification of Surgical Complications - Abstract July 9, 2012

Embolisation of bone metastases from renal cancer - Abstract July 9, 2012

Randomized phase II trial of sunitinib on an intermittent versus continuous dosing schedule as first-line therapy for advanced renal cell carcinoma - Abstract July 6, 2012

Nephron sparing surgery in von Hippel-Lindau associated renal cell carcinoma; clinicopathological long-term follow-up - Abstract July 6, 2012

Cigarette smoking and renal cell carcinoma risk among black and white Americans: Effect modification by hypertension and obesity - Abstract July 5, 2012

Evaluation of treatment options for patients with advanced renal cell carcinoma: Assessment of appropriateness, using the validated semi-quantitative RAND corporation/University of California, Los Angeles methodology - Abstract July 5, 2012

The effect of sunitinib on primary renal cell carcinoma and facilitation of subsequent surgery - Abstract July 4, 2012

External validation of a nomogram using RENAL nephrometry score to predict high grade renal cell carcinoma - Abstract July 4, 2012

Renal cell carcinoma associated with peritumoral sarcoid-like reaction without intratumoral granuloma - Abstract July 3, 2012

A phase I study of sorafenib and vorinostat in patients with advanced solid tumors with expanded cohorts in renal cell carcinoma and non-small cell lung cancer - Abstract July 2, 2012

Economic evaluation of first-line treatments for metastatic renal cell carcinoma: A cost-effectiveness analysis in a health resource-limited setting - Abstract July 2, 2012

Current treatment considerations in metastatic renal cell carcinoma - Abstract July 2, 2012

Bisphosphonates combined with sunitinib may improve the response rate, progression free survival and overall survival of patients with bone metastases from renal cell carcinoma - Abstract June 29, 2012

Systematic review of oncological outcomes following surgical management of localised renal cancer - Abstract June 29, 2012

Under-grading of less than 4 cm renal masses on renal biopsy - Abstract June 28, 2012

Page 420 of 456